Clinical trial
Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients
NCT02750007
Study timeline
Study start (unknown)2015-12-01Date precision: month
Registry last updated2016-04-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
HS-20004DRUG
Sponsors & collaborators
Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02750007 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.